Tecan, Innovatis Ink Co-marketing Plan | GenomeWeb

NEW YORK (GenomeWeb News) – Tecan said today that it will collaborate with Innovatis to jointly market robotic cell culture workstations and cell detection devices.

Under the agreement, the companies will co-market Innovatis' Cellavista automated image-based cellular analysis platform and Tecan's Freedom EVO platform. Used together, Tecan said, the platforms allow automation of a wide range of cell-related processes including cell line development, cell proliferation, stem cell differentiation, and cell-based assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.